🇺🇸 FDA
Pipeline program

Zometa 4 mg/100 ml solution for infusion

UC-0150/ 0603

Phase 3 small_molecule active

Quick answer

Zometa 4 mg/100 ml solution for infusion for High grade osteosarcoma is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Cancer Prevention Pharma (Ireland) Limited
Indication
High grade osteosarcoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials